Correlation Between Dupont De and Genscript Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dupont De and Genscript Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dupont De and Genscript Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dupont De Nemours and Genscript Biotech, you can compare the effects of market volatilities on Dupont De and Genscript Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dupont De with a short position of Genscript Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dupont De and Genscript Biotech.

Diversification Opportunities for Dupont De and Genscript Biotech

-0.32
  Correlation Coefficient

Very good diversification

The 3 months correlation between Dupont and Genscript is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Dupont De Nemours and Genscript Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genscript Biotech and Dupont De is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dupont De Nemours are associated (or correlated) with Genscript Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genscript Biotech has no effect on the direction of Dupont De i.e., Dupont De and Genscript Biotech go up and down completely randomly.

Pair Corralation between Dupont De and Genscript Biotech

Allowing for the 90-day total investment horizon Dupont De Nemours is expected to generate 0.41 times more return on investment than Genscript Biotech. However, Dupont De Nemours is 2.46 times less risky than Genscript Biotech. It trades about 0.03 of its potential returns per unit of risk. Genscript Biotech is currently generating about -0.01 per unit of risk. If you would invest  6,802  in Dupont De Nemours on August 25, 2024 and sell it today you would earn a total of  1,530  from holding Dupont De Nemours or generate 22.49% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Dupont De Nemours  vs.  Genscript Biotech

 Performance 
       Timeline  
Dupont De Nemours 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Dupont De Nemours are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound fundamental indicators, Dupont De is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.
Genscript Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Genscript Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Dupont De and Genscript Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dupont De and Genscript Biotech

The main advantage of trading using opposite Dupont De and Genscript Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dupont De position performs unexpectedly, Genscript Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genscript Biotech will offset losses from the drop in Genscript Biotech's long position.
The idea behind Dupont De Nemours and Genscript Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Technical Analysis
Check basic technical indicators and analysis based on most latest market data
CEOs Directory
Screen CEOs from public companies around the world
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format